Arunjyoti Bio Ventures reported a turnaround to profitability in Q1 FY27 with a net profit of ₹0.61 crore, up from a ₹5.40 crore loss. The company also announced a proposed name change to Pasura Industries Limited, subject to shareholder approval.
Arunjyoti Bio Ventures Returns to Profitability, Eyes Name Change to Pasura Industries
Arunjyoti Bio Ventures Ltd has reported a return to profitability in the first quarter of fiscal year 2027 (Q1 FY27), posting a net profit of ₹0.61 crore (₹61.24 lakh).
This marks a significant turnaround from a net loss of ₹5.40 crore (₹540.09 lakh) in the previous quarter (Q4 FY26).
Reader Takeaway: Profitability turnaround and name change to Pasura Industries are key investor watchpoints.
What just happened
The company's financial performance for the quarter ended 30 June 2026, showed a sequential revenue growth of 13.3% to ₹8.20 crore from ₹7.24 crore in the preceding quarter. This revenue increase contributed to the company's shift from a net loss to a net profit.
Why this matters
The return to profitability is a crucial positive signal for shareholders, indicating improved operational performance. The proposed name change to Pasura Industries Limited, pending member approval, signals a potential strategic shift or rebranding for the company.
The backstory
In the fiscal year 2026, Arunjyoti Bio Ventures faced significant losses. The Q1 FY27 results demonstrate a recovery trajectory. The company also approved a waiver for excess managerial remuneration paid in FY 2025-26, subject to shareholder consent.
What changes now
Shareholders will vote on the proposed name change and the waiver for excess managerial remuneration at the upcoming 40th Annual General Meeting (AGM) on 12 August 2026. The company has also appointed a new secretarial auditor, M/s. Vivek Surana & Associates, for a five-year term.
Risks to watch
Key risks include the outcome of the shareholder vote on managerial remuneration waivers and the successful completion of the name change process. Revisions to key managerial personnel remuneration also warrant attention.
Peer comparison
(No peer comparison data was available in the provided filing content.)
Context metrics (time-bound)
- Q1 FY27 Net Profit: ₹0.61 crore (₹61.24 lakh)
- Q4 FY26 Net Loss: (₹5.40 crore) ((₹540.09 lakh))
- Q1 FY27 Revenue: ₹8.20 crore
- Q4 FY26 Revenue: ₹7.24 crore
- AGM Date: 12 August 2026
What to track next
Investors should track the approvals for the name change and remuneration waivers, as well as future quarterly results to confirm sustained profitability and revenue growth.